MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice

• Ping-Ping He ,

  Contributed equally to this work with: Ping-Ping He, Xin-Ping OuYang, Yuan Li

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China, Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, 28 West Changsheng Road, Hengyang 421001, Hunan, China, Nursing School, University of South China, Hengyang 421001, Hunan, China

  ⨯
• Xin-Ping OuYang ,

  Contributed equally to this work with: Ping-Ping He, Xin-Ping OuYang, Yuan Li

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China, Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, 28 West Changsheng Road, Hengyang 421001, Hunan, China, Department of Physiology, The Neuroscience Institute, Medical College, University of South China,Hengyang, Hunan, 421001, China

  ⨯
• Yuan Li ,

  Contributed equally to this work with: Ping-Ping He, Xin-Ping OuYang, Yuan Li

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Yun-Cheng Lv,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Zong-Bao Wang,

  Affiliations Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, 28 West Changsheng Road, Hengyang 421001, Hunan, China, Pharmacy and Biological Science College, University of South China, Hengyang, Hunan, 421001, China

  ⨯
• Feng Yao,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Wei Xie,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Yu-Lin Tan,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Liang Li,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Min Zhang,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Gang Lan,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Duo Gong,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Hai-Peng Cheng,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Hui-Juan Zhong,

  Affiliation Department of Cardiovascular Medicine, The Liwan Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510170, China

  ⨯
• Dan Liu,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Chong Huang,

  Affiliation Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China

  ⨯
• Zhao-Xia Li,

  Affiliation Nursing School, University of South China, Hengyang 421001, Hunan, China

  ⨯
• Xi-Long Zheng,

  Affiliation Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, The University of Calgary, Health Sciences Center, 3330 Hospital Dr NW, Calgary, Alberta, Canada

  ⨯
• Wei-Dong Yin ,

  * E-mail: tangchaoke@qq.com (CKT); wdy20042004@126.com (WDY)

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China, Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, 28 West Changsheng Road, Hengyang 421001, Hunan, China, Pharmacy and Biological Science College, University of South China, Hengyang, Hunan, 421001, China

  ⨯
•  [ ... ],
• Chao-Ke Tang

  * E-mail: tangchaoke@qq.com (CKT); wdy20042004@126.com (WDY)

  Affiliations Institute of Cardiovascular Research, Key Laboratory for Atherosclerologyof Hunan Province,Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, University of South China,Hengyang, Hunan 421001, China, Hunan Province Cooperative innovation Center for Molecular Target New Drug Study, 28 West Changsheng Road, Hengyang 421001, Hunan, China

  ⨯
• [ view all ]
• [ view less ]